Ascites
Renal function varies enormously in patients with ascites, values for glomerular filtration rate and renal plasma flow showing a complete spectrum from twice normal down to those found with significant renal impairment. When renal failure is present, the markedly reduced filtration of sodium may be sufficient alone to explain the fluid retention, but for those with well preserved renal function other factors acting on the renal tubules must be implicated. It is possible to determine the nephron site for abnormal sodium retention under conditions of a maximum water diuresis. Although the increased sodium reabsorption has been shown to occur throughout the nephron the greatest difference between patients with and without sodium retention is in the distal segment (distal convulted tubule or collecting tubule) (Fig 1) . 5 Hormonal and neural factors affecting this part of the nephron include aldosterone, atrial natriuretic hormone and the sympathetic nervous system.
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
The concept has developed that cirrhosis is a high renin high aldosterone state. This has not, however, been confirmed in many studies in which only 35-50% of patients accumulating ascites have increased values (Fig 2) 5-8 Furthermore, before there is clinical evidence for fluid retention the renin-angiotensin-aldosterone system has been reported to be suppressed. In view of the normal values for aldosterone in a number of patients actively retaining sodium its pathogenic importance has been questioned. Evidence in favour of a dominant role for aldosterone include: (a) renal sodium excretion is closely related to plasma concentration and the renal excretion of aldosterone whatever the state of sodium balance5; (b) blood volume, and expression of renal sodium retention, correlates well with the plasma aldosterone concentration9; (c) the aldosterone antagonist spironolactone or adrenalectomy will almost invariably reverse the sodium retention, provided renal failure is not already present'°"; (d) during P-adrenergic blockade it was observed that the renal sodium excretion increased or decreased exactly as predicted by the changes in aldosterone. ' ympathetic compartments this could explain the suppression iscites, and of the renin-angiotensin-aldosterone system ion. 17 More which would result in a return to sodium balance todels have at a higher concentration of total body sodium. n retention The process would be accentuated by reduced i is dener-renal sensitivity to atrial natriuretic hormone.
An alternative explanation to the traditional concept for ascites formation is 'the overflow theory. ' system in the vasodilatation.38 On the other hand, patients with hepatorenal syndrome exhibited femoral blood flow close to normal subjects suggesting that splanchnic vasodilatation was extreme causing intense activation of the pressor systems.
There is marked activation of the sympathoadrenal system in advanced liver disease, and the degree of activation follows the degree of decompensation.3' The kidneys are richly innervated by the sympathetic system which, when activated, increase renal vascular resistance. Early studies of a-adrenergic blockade by phentolamine infusion produced no improvement in renal function, although any beneficial effect was offset by a fall in mean arterial pressure.32 More recently, a novel approach has used lumbar sympathetic blockade of the sympathetic nerves, which produced an increase in renal blood flow in all eight subjects studied, but only five subjects showed an improvement in glomerular filtration rate, and three showed an actual deterioration.33 Thirdly, studies in which head out ofwater immersion have followed serial changes in glomerular filtration rate and plasma noradrenaline concentrations did not observe suppression of noradrenaline in nine out of 15 subjects in whom there was an improvement in glomerular filtration rate.34 Thus, increased sympathetic activity may be an important factor reducing glomerular filtration rate in some but not all patients with hepatorenal syndrome.
As already discussed the renin-angiotensin system is activated in decompensated liver disease. 6 Endotoxins are the lipopolysaccharide components of the cell wall of gram negative bacilli. They are thought to be responsible for many of the manifestations of gram negative septicaemia in man, and are known to be vasoconstrictor in the renal circulation in animals. In advanced liver disease, there appears to be failure of the reticuloendotheliac system to remove endotoxins absorbed from the gut, and direct absorption through portasystemic collaterals into the systemic circulation. Several studies have shown a higher incidence of endotoxaemia in the systemic circulation in hepatorenal syndrome36 38 (Fig 3) . Other toxins such as staphylococcal toxin may act synergistically with endotoxins and may account for some of the discrepant results reported by other groups. Supportive evidence is also provided by more recent studies in which daily culture of blood, urine, sputum, ascites, as well as daily nasopharyngeal/vaginal swabs, have shown a higher incidence of bacterial infection and fungal infection in patients with fulminant hepatic failure developing hepatorenal syndrome. 39 If endotoxins or indeed other bacterial toxins are important in the pathogenesis of hepatorenal syndrome, what is the mechanism? Several lines of investigation have shown that endotoxins activate formation of the eicosanoids. This is either through a direct effect on circulating monocytes or tissue resident macrophages. Eicosanoids comprise in part the prostaglandins, thromboxane A2, and the cysteinyl-leukotrienes (LTC4, LTD4, and LTE4). These may be classified into renal vasodilators (PGE2, and prostacyclin) and renal vasoconstrictors (TXA2, and LTC4 and LTD4), as well as causing relaxation or contraction of the mesangium respectively. The role of thromboxane A2 is controversial. Some studies have reported increased renal production while others have suggested that there is normal or decreased production of thromboxane A2 as assessed by urinary excretion rate or concentration of its stable metabolite TXB2 (40) (41) (42) (43) . More recent studies have suggested that while there is increased renal and systemic production of thromboxane A2 in hepatorenal syndrome,"4 this was not significantly greater than that in subjects appropriately controlled for severity of hepatic dysfunction but with relatively normal renal function. Thus, increased production appears to primarily reflect the severity of liver disease.
The vasodilatory prostaglandins are important in maintaining renal function in patients with decompensated liver disease. Renal production of PGE2 and prostacyclin is increased in patients with ascites,31 41 
